Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -189,291 | -76,970 | -86,420 | -120,875 | -58,068 |
| Depreciation Amortization | 22,150 | 17,787 | 6,520 | 7,943 | 8,769 |
| Accounts receivable | -11,973 | 35,229 | -55,232 | 1,996 | 4,957 |
| Accounts payable and accrued liabilities | 17,731 | -3,051 | 3,630 | -714 | -298 |
| Other Working Capital | 174,630 | -85,659 | -48,398 | 9,018 | 24,523 |
| Other Operating Activity | 68,355 | 33,959 | 103,756 | 36,119 | 27,225 |
| Operating Cash Flow | $81,602 | $-78,705 | $-76,144 | $-66,513 | $7,108 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,414 | -411,299 | -576,880 | -169 | 7,874 |
| PPE Investments | -3,994 | -5,755 | -7,836 | -8,495 | -1,252 |
| Purchase Of Investment | -3,896 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 457,963 | 537,072 | 62,593 | 78,530 | N/A |
| Investing Cash Flow | $452,487 | $120,018 | $-522,123 | $69,866 | $6,622 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 49 | 0 | N/A |
| Debt Repayment | -13,023 | -12,328 | -409 | -403 | -403 |
| Common Stock Issued | 37,829 | 20,778 | 29,847 | 506,115 | 9,881 |
| Other Financing Activity | -11,463 | -12,750 | -15,612 | -9,240 | -2,740 |
| Financing Cash Flow | $13,343 | $-4,300 | $13,875 | $496,472 | $6,738 |
| Exchange Rate Effect | 4,695 | -5 | -8 | 51 | -10 |
| Beginning Cash Position | 126,266 | 89,258 | 673,658 | 173,782 | 153,324 |
| End Cash Position | 678,393 | 126,266 | 89,258 | 673,658 | 173,782 |
| Net Cash Flow | $552,127 | $37,008 | $-584,400 | $499,876 | $20,458 |
| Free Cash Flow | |||||
| Operating Cash Flow | 81,602 | -78,705 | -76,144 | -66,513 | 7,108 |
| Capital Expenditure | -3,994 | -5,762 | -8,020 | -8,500 | -1,252 |
| Free Cash Flow | 77,608 | -84,467 | -84,164 | -75,013 | 5,856 |